Super P Force

Basic Super P Force Information

• INN (International Nonproprietary Name): Sildenafil (PDE5 inhibitor); Dapoxetine (Selective Serotonin Reuptake Inhibitor, SSRI).
• Brand Names Available In Canada (English): Super P-Force and Extra Super P-Force are manufactured and marketed internationally but are typically not registered in Canada; sildenafil and dapoxetine are available individually as products to check by DIN.
• ATC Code: Sildenafil — G04BE03. Dapoxetine — not officially assigned; often considered under N06BX21 in some databases.
• Forms & Dosages: Tablet 100 mg sildenafil + 60 mg dapoxetine; oral administration; typical international pack sizes 4, 8, 12, 24 tablets.
• Manufacturers In Canada (English): Not specified. Manufacturers listed in source data include Indian companies such as Sunrise Remedies and Centurion Laboratories.
• Registration Status In Canada (English): Typically unlicensed as a fixed combination; verify with Health Canada and provincial authorities before supply.
• OTC / Rx Classification: Prescription-only (Rx) in regulated countries, including Canada.

Critical Warnings & Restrictions In Canada

Safety-First Summary For Canadian Patients

Super P-Force combines sildenafil and dapoxetine in a single tablet and is prescription-only in regulated markets.

The fixed combination is commonly manufactured in India and is typically unlicensed outside those markets, making it unlikely to have a Canadian DIN.

Anyone taking nitrates must not take this product because the combination with sildenafil can cause severe, life‑threatening hypotension.

Dapoxetine is serotonergic and raises the risk of serotonin syndrome when used with other SSRIs, SNRIs, MAO inhibitors, or certain triptans.

Priapism (painful erection lasting more than four hours) is a rare but urgent adverse event that requires immediate medical attention.

Do not use this combination after recent myocardial infarction, unstable angina, recent stroke, severe liver impairment, or known hypersensitivity to sildenafil or dapoxetine.

• Emergency Signs Checklist: loss of consciousness, chest pain, severe dizziness, fainting, prolonged erection (>4 hours), high fever with agitation — seek emergency care.

• Absolute Contraindications: concurrent nitrate therapy; known hypersensitivity to sildenafil or dapoxetine; recent myocardial infarction; unstable angina; recent stroke; severe liver impairment; history of mania or bipolar disorder.

Q&A — “Can I Drive After Taking It In Canada?”

Q: Can I drive after taking Super P-Force?

A: If you experience dizziness, visual disturbance, sleepiness, or impaired reaction time after taking the tablet, do not drive or operate heavy machinery.

A: Canadian occupational safety law and provincial driving regulations require fitness to drive; report adverse effects to your prescriber and pharmacist.

High-Risk Groups

Elderly patients have a higher prevalence of cardiovascular disease and polypharmacy, increasing interaction risk with sildenafil and dapoxetine.

Begin at a lower dose and consider cardiology input when cardiovascular disease or multiple interacting drugs are present.

Pregnant or breastfeeding people should not use this product; dapoxetine is an SSRI with unclear neonatal safety and these tablets are not indicated for women.

For Indigenous and remote communities, prioritise culturally safe care, medication reconciliation, clear counselling, and planning for access barriers such as telehealth or travel for assessment.

Documentation of cardiovascular disease, psychiatric history (particularly mania or bipolar disorder), and liver or kidney dysfunction is essential before prescribing.

Interaction With Activities

Sildenafil may cause dizziness and transient visual changes that can impair driving.

Dapoxetine can cause dizziness, insomnia, or somnolence and may also impair reaction time.

Patients should not drive or operate heavy machinery until they know how the combination affects them.

Usage Basics For Canadians

INN, Brand Names Available In Canada

INNs are sildenafil (a phosphodiesterase‑5 inhibitor) and dapoxetine (a short‑acting SSRI).

Combination brands such as Super P-Force and Extra Super P-Force are commonly manufactured in India and sold internationally but are typically not registered in Canada.

In Canada, sildenafil is widely available as generic and branded products; dapoxetine is less commonly used or available and should be checked case-by-case for DINs.

• Brand Vs Generic: Brand examples include Viagra for sildenafil; generic sildenafil is marketed by manufacturers such as Teva or Sandoz internationally.

INN

Official, generic name of the active ingredient (e.g., sildenafil).

Brand

Manufacturer or trade name under which a product is sold (e.g., Super P-Force internationally; Viagra in Canada for sildenafil).

Legal Classification Under Health Canada

Sildenafil and dapoxetine are prescription-only in Canada.

A fixed-dose combination like Super P-Force that lacks Health Canada approval will not have a DIN and may be considered an unlicensed import.

Prescribers and pharmacists should document informed consent when considering unlicensed imports and favour DIN‑approved alternatives available through Canadian supply channels.

Pharmacists are expected to refuse supply of unlicensed or unverifiable imports according to professional standards and provincial college guidance.

Canadian Dosing Guide

Standard Regimens (Health Canada Approved)

There is no Health Canada–approved fixed combination sildenafil + dapoxetine tablet.

Internationally, the common marketed fixed tablet contains sildenafil 100 mg and dapoxetine 60 mg taken 1–3 hours before intercourse, with a limit of one tablet per 24 hours.

Sildenafil monotherapy dosing varies by product monograph in Canada; start at a lower dose for patients with comorbidities or interacting medications.

Dapoxetine dosing is aligned with international products and emphasises psychiatric risk screening prior to use.

• Dosing Checklist: confirm indication (ED + PE), review cardiac history, review interacting meds (nitrates, potent CYP3A4 inhibitors), advise one tablet PRN 1–3 hours before activity, do not exceed one tablet in 24 hours.

Adjustments For Comorbidities

Reduce dose or avoid use in moderate to severe hepatic or renal impairment due to increased exposure and adverse effects risk.

For elderly patients, review all comorbidities and medications, and consider cardiology review before initiating sildenafil.

Diabetes increases the prevalence of erectile dysfunction in Canada; counsel patients on glycaemic control and perform cardiovascular risk assessment before sexual activity.

Q&A — “What If I Miss A Dose Under My Provincial Drug Plan?”

Q: What if I miss my dose?

A: Super P-Force is taken as needed before intercourse, so there is no routine “missed dose” action.

A: Do not double the dose within 24 hours.

A: If using a provincially covered product with refill rules, contact your pharmacy or your provincial drug plan (for example, ODB, BC PharmaCare, RAMQ) for coverage or replacement procedures.

Interaction Chart

Food And Drinks

Alcohol can worsen sildenafil-related hypotension and increase dizziness.

Combining dapoxetine with alcohol increases risk of syncope, impaired judgment, and can worsen side effects like dizziness.

Caffeine is not a major interaction but may accentuate palpitations when combined with stimulants or anxiety from sexual activity.

• Key counselling points: avoid heavy alcohol around dosing, warn about dizziness and visual changes, advise testing effects before driving, and keep medication list for pharmacy reconciliation.

Common Drug Conflicts

Absolute contraindication exists for nitrates due to profound hypotension risk with sildenafil.

Alpha-blockers can cause additive blood pressure lowering — use caution and consider staggered dosing or lower sildenafil dose.

Potent CYP3A4 inhibitors such as certain azole antifungals or some protease inhibitors increase sildenafil exposure and may necessitate dose reduction.

Dapoxetine interacts dangerously with MAO inhibitors and with other SSRIs/SNRIs or triptans due to serotonin syndrome risk.

Pharmacist-led medication reconciliation and interaction checks are essential and should be documented and communicated to the prescriber.

User Reports & Trends In Canada

Canadian Patient Forums And Review Platforms

Many Canadian users discuss sourcing and authenticity concerns on forums when the combination is not available domestically.

Common themes include difficulty obtaining a combination product with a Canadian DIN and worry about counterfeit or substandard imports.

Patients often prefer pharmacist consultation and DIN‑verified products over international online purchases.

• Patient concerns summary: authenticity of imports; unclear regulatory status; side effect reports like dizziness, headache, and sleep disturbance; preference for pharmacist advice.

An anonymised example: a patient posted about ordering Super P-Force from an international site, then asked a pharmacist to verify packaging and was counselled to switch to a DIN‑registered sildenafil plus monitored dapoxetine prescription instead.

Community Pharmacy Feedback

Pharmacists report frequent questions about combo tablets and prioritise dispensing DIN-registered alternatives when possible.

Community pharmacists check for interacting medications such as nitrates and antidepressants and document counselling and adverse events.

When patients request imported products, pharmacists advise on regulatory and safety risks and recommend reporting adverse events to Canada Vigilance.

Access & Purchase Options

National Pharmacy Chains & Provincial Realities

Major pharmacy chains such as Shoppers Drug Mart, Rexall, London Drugs, and Jean Coutu dispense DIN‑approved sildenafil formulations with a prescription.

A combination like Super P-Force is unlikely to be stocked legally in Canadian chains without Health Canada approval.

Patients seeking the combination may find international e-pharmacies; imports may be unlicensed and pose legal and safety risks.

• Safe purchasing checklist: obtain prescription, verify DIN on product, use licensed Canadian pharmacy, check packaging and expiry, confirm pharmacist counselling.

In our online pharmacy, super p force is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Online Pharmacies In Canada & Provincial Restrictions

Use only Canadian-licensed online pharmacies with verifiable credentials and a listed pharmacy licence number.

Provincial regulatory colleges may restrict dispensing of unapproved combination products; pharmacists should verify DINs and follow college guidance.

When in doubt, pharmacists should refuse unverifiable products and recommend DIN-registered alternatives or specialist referral.

Mechanism & Pharmacology

Simplified Explanation (Patient-Friendly)

Sildenafil

Inhibits phosphodiesterase type‑5 to enhance nitric oxide–mediated vasodilation in the penis, aiding erection.

Dapoxetine

Short‑acting SSRI that increases serotonin activity to delay ejaculation.

The rationale for combining the two is to treat coexisting erectile dysfunction and premature ejaculation simultaneously, as described in international product data.

Suggest a simple infographic showing sexual arousal → nitric oxide → PDE5 action → sildenafil effect; and serotonin pathways for ejaculation control with dapoxetine.

Clinical Terms And Monograph References

Refer to individual Health Canada product monographs for sildenafil and for dapoxetine where available.

Sildenafil ATC classification is G04BE03; dapoxetine is often catalogued under other antidepressants (N06BX21) in some databases.

Use plain language during counselling while retaining clinical accuracy about onset, duration, and side effect profiles.

Indications & Off-Label Uses In Canada

Approved Indications (DIN)

Sildenafil is approved in Canada for erectile dysfunction when supplied as a DIN‑registered product.

Dapoxetine may not have widespread DIN availability for premature ejaculation in Canada and should be checked per product monograph.

A fixed‑dose sildenafil + dapoxetine combination typically lacks Health Canada approval and therefore has no Canadian indication or DIN.

• On-Label Uses: Sildenafil for ED when supplied as a DIN product.
• Off-Label Uses: Co-prescribing separate sildenafil and dapoxetine products for concurrent ED and PE under specialist oversight.

DIN

Drug Identification Number required for marketed prescription drugs in Canada.

Indication

Condition for which the product is approved by regulators.

Common Off-Label Practices

Some clinicians prescribe sildenafil and dapoxetine as individual agents concurrently to manage coexisting ED and PE.

Off-label combinations require clear informed consent, psychiatric screening prior to dapoxetine, and cardiovascular assessment before sildenafil.

Careful documentation and follow-up monitoring are standard practice for off-label therapy in Canada.

Key Clinical Findings

Canadian And International Studies 2022–2025

• Evidence gaps: Limited high-quality long-term Canadian RCT data on fixed combination products; reliance on individual active‑ingredient studies for risk/benefit counselling.

Ongoing Health Canada Safety Monitoring

Adverse events should be reported to Canada Vigilance by clinicians and patients.

Clinicians must submit serious event reports and consider regulatory reporting for unlicensed imports to inform pharmacovigilance and coverage decisions.

Alternatives Matrix

Comparable Medicines With DIN In Canada

Pros And Cons Checklist

• Review cardiovascular risk profile before choosing a PDE5 inhibitor.
• Decide on on‑demand versus daily dosing based on patient preference and comorbidities.
• Consider interaction profiles, provincial coverage, and out-of-pocket cost.
• Use shared decision-making to select the safest, DIN‑approved option when possible.

Common Questions From Canadian Patients

• Is an online Super P-Force purchase authentic? — Verify packaging, DIN (if present), and prefer Canadian-licensed pharmacies.
• Can I take nitrates with this medication? — No. Nitrates are an absolute contraindication.
• Can I drive after taking it? — Avoid driving if you feel dizzy, sleepy, or have visual disturbances.
• Is it covered by provincial plans? — Fixed combinations without a DIN are typically not covered; DIN‑approved sildenafil may be covered under specific criteria.
• What to do for an erection lasting more than 4 hours? — Seek emergency care immediately for priapism.
• Where to report adverse events? — Report to Canada Vigilance and inform your prescriber and pharmacist.

Action steps for emergencies: stop the medication, seek urgent care for severe hypotension or priapism, and bring the medication packaging if possible.

Coverage & Purchase Comparison Table

Comparison Table — Province/Plan

• Checklist To Appeal Coverage: obtain prescriber’s clinical rationale, request exceptional access or special authorisation, and submit required documentation to the provincial drug program.

Step-By-Step Purchase Checklist For Canadian Patients

• See a prescriber for a full medical assessment and cardiovascular screening.
• Obtain a prescription that names DIN‑approved alternatives when available.
• Verify the DIN on any product before purchase.
• Use a licensed Canadian pharmacy for dispensing and counselling.
• Check provincial plan eligibility and coverage rules before ordering.
• Confirm counselling on interactions, driving, alcohol, and emergency signs at point of supply.

Registration & Regulation

Health Canada Approval

A fixed Super P-Force combination tablet is typically unlicensed in Canada and lacks a Canadian DIN unless a dossier has been submitted and approved by Health Canada.

Clinicians and pharmacists should verify product registration and avoid dispensing unregistered combination imports without regulatory guidance.

For sildenafil and dapoxetine individually, consult product monographs and DIN listings for approved formulations and prescribing information.

DIN

Drug Identification Number required for marketed drugs in Canada.

NOC

Notice of Compliance — indicates regulatory approval.

Canada Vigilance

Health Canada’s adverse reaction reporting system.

• Steps To Verify Registration: check Health Canada databases for DIN/NOC, confirm labelling and bilingual information, consult provincial college guidance for unlicensed imports.

DIN Number And Labelling Requirements

Canadian labelling requires bilingual patient information where applicable and a valid DIN for pharmacy dispensing.

Imported blister packs from international suppliers often lack Canadian bilingual labelling and DINs, creating regulatory and safety concerns.

Pharmacists should refuse to dispense products missing required labelling or verifiable origin and recommend DIN‑approved alternatives.

Storage & Handling

Standard Canadian Household Conditions

Store tablets below 30°C in the original blister packaging away from light and moisture.

Keep out of reach of children and do not use after the expiry date.

Avoid storing in bathrooms or near heat sources.

Advise patients in northern or remote communities to avoid freezing or extreme heat during transport and storage.

• Patient storage checklist: keep in original pack, note expiry date, avoid moisture and heat, store out of reach of children.

Cold-Chain Requirements (Where Applicable)

No cold-chain storage is required for sildenafil or dapoxetine tablets per product information.

Emphasise secure transport for mail orders, verification of tamper-evidence, and refusal of suspicious packaging on receipt.

Guidelines For Proper Use

Canadian Pharmacist Guidance

Confirm the indication and perform a thorough medical history, including cardiovascular status and psychiatric history.

Perform medication reconciliation to identify nitrates, antidepressants, and potent CYP3A4 inhibitors.

Counsel on dosing: one tablet PRN taken 1–3 hours before intercourse; do not exceed one tablet in 24 hours.

Advise patients about side effects and emergency signs such as priapism and severe hypotension, and report adverse events to Canada Vigilance.

If the product lacks a DIN, refuse dispensing and recommend DIN‑approved alternatives.

• Sample counselling script bullet points: explain indication, confirm current meds, discuss side effects, advise on alcohol and driving, and document counselling in the patient record.

Provincial Health Authority Recommendations

Follow provincial regulatory college guidance regarding unlicensed imports and informed consent procedures.

For exceptional access or special authorisations, document the clinical rationale and implement close monitoring and follow-up.

Provide patient handouts in English and French and consider Indigenous cultural safety practices and local access barriers.

Delivery Across Canada (English)